Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS
· Delayed Price · Currency is USD
1.880
-0.013 (-0.69%)
Dec 20, 2024, 4:00 PM EST
Medexus Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 2.3 | -0.21 | 1.22 | -2.88 | -28.26 | -4.7 | Upgrade
|
| Depreciation & Amortization | 5.88 | 5.81 | 6.08 | 6.14 | 5.98 | 3.92 | Upgrade
|
| Other Amortization | - | - | - | 0 | 0 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.35 | 0.89 | - | 1.75 | - | 0.69 | Upgrade
|
| Stock-Based Compensation | 0.62 | 0.47 | 1.22 | 1.88 | 1.27 | 1.48 | Upgrade
|
| Other Operating Activities | 4.26 | 9.42 | 5.3 | -12.81 | 25.88 | -1.53 | Upgrade
|
| Change in Accounts Receivable | 9.59 | -1.68 | -8.24 | 4.43 | -3.51 | -7.73 | Upgrade
|
| Change in Inventory | -13.01 | -6.75 | -1.99 | -6.66 | -0.01 | 1.06 | Upgrade
|
| Change in Accounts Payable | 2.74 | 8.58 | 4.75 | 3.61 | 4.63 | 4.95 | Upgrade
|
| Change in Other Net Operating Assets | 6.46 | 2.19 | -9.79 | 3.36 | -0.93 | 0.13 | Upgrade
|
| Operating Cash Flow | 22.2 | 18.71 | -1.44 | -1.18 | 5.04 | -1.73 | Upgrade
|
| Capital Expenditures | -0.08 | -0.05 | -0.06 | -0.1 | -0.12 | -0.08 | Upgrade
|
| Cash Acquisitions | -2.96 | -3.21 | -1.36 | -0.48 | -0.95 | -29.64 | Upgrade
|
| Sale (Purchase) of Intangibles | -2.72 | -0.22 | -0.3 | -7.62 | -10.64 | -0.82 | Upgrade
|
| Other Investing Activities | - | - | - | - | - | 0.22 | Upgrade
|
| Investing Cash Flow | -5.75 | -3.48 | -1.72 | -8.2 | -11.71 | -30.32 | Upgrade
|
| Long-Term Debt Issued | - | 17.58 | 35.46 | 3.89 | 0.35 | 20 | Upgrade
|
| Total Debt Issued | 17.58 | 17.58 | 35.46 | 3.89 | 0.35 | 20 | Upgrade
|
| Long-Term Debt Repaid | - | -43.99 | -24.72 | -0.16 | -0.37 | -0.33 | Upgrade
|
| Total Debt Repaid | -49.59 | -43.99 | -24.72 | -0.16 | -0.37 | -0.33 | Upgrade
|
| Net Debt Issued (Repaid) | -32.01 | -26.4 | 10.73 | 3.73 | -0.02 | 19.67 | Upgrade
|
| Issuance of Common Stock | 7.61 | 7.61 | - | - | 22.64 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | - | -2.81 | Upgrade
|
| Other Financing Activities | -4.62 | -4.25 | -4.33 | -3.07 | -3.93 | -1.43 | Upgrade
|
| Financing Cash Flow | -29.03 | -23.05 | 6.41 | 0.66 | 18.68 | 15.42 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.05 | -0 | -0.19 | 0.03 | 1.45 | 0.01 | Upgrade
|
| Net Cash Flow | -12.53 | -7.81 | 3.05 | -8.69 | 13.47 | -16.62 | Upgrade
|
| Free Cash Flow | 22.12 | 18.66 | -1.51 | -1.28 | 4.92 | -1.81 | Upgrade
|
| Free Cash Flow Margin | 21.12% | 16.51% | -1.39% | -1.66% | 6.18% | -3.26% | Upgrade
|
| Free Cash Flow Per Share | 0.90 | 0.83 | -0.07 | -0.06 | 0.32 | -0.13 | Upgrade
|
| Cash Interest Paid | 4.62 | 4.25 | 4.33 | 3.07 | 3.64 | 1.07 | Upgrade
|
| Cash Income Tax Paid | 1.21 | 1.42 | 0.91 | 0.68 | 0.87 | 0.45 | Upgrade
|
| Levered Free Cash Flow | 9.21 | 8.47 | -8.98 | -10.18 | -8.96 | -8.4 | Upgrade
|
| Unlevered Free Cash Flow | 14.88 | 16.83 | -0.48 | -2.54 | -2.82 | -4.11 | Upgrade
|
| Change in Net Working Capital | -2.79 | -2.36 | 13.08 | -4.47 | -0.03 | 8.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.